You have 6 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IFN-beta 2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Learn About Interferon-beta Exposure of Pregnant Women During

Not yet recruiting
  • Multiple Sclerosis (MS)
  • Avonex (IFNβ-1-a, Biogen Netherlands B.V)
  • +5 more
  • Multiple Locations, Finland
  • +1 more
Sep 19, 2023

Covid19 Trial in United States (IFN beta-1a, Dexamethasone)

Terminated
Has Results
  • Covid19
  • Aurora, Colorado
  • +3 more
Oct 13, 2022

Gene Expression Of Suppressor Of Cytokines in In Cutaneous Warts

Not yet recruiting
  • Warts
  • Detection of expression of SOCS3 gene
  • +2 more
  • (no location specified)
Mar 12, 2023

Relapsing Multiple Sclerosis Trial (Placebo, BIIB061, Interferon-beta1)

Not yet recruiting
  • Relapsing Multiple Sclerosis
  • Placebo
  • +3 more
  • (no location specified)
Mar 22, 2021

Pediatric Hearing Loss Due to OTOF, GJB2, or GJB2/GJB6 Mutations

Not yet recruiting
  • Congenital Hearing Loss Secondary to Biallelic Mutations in the Otoferlin Gene (OTOF)
  • +2 more
    • (no location specified)
    Aug 25, 2023

    Multiple Sclerosis Trial in Worldwide (Cladribine, Placebo, Interferon-beta (IFN-beta))

    Completed
    Has Results
    • Multiple Sclerosis
    • Cullman, Alabama
    • +38 more
    Oct 8, 2020

    Vaccine Reaction, COVID-19 Trial in Paris (Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech), VidPrevtyn® Beta

    Not yet recruiting
    • Vaccine Reaction
    • COVID-19
    • Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech)
    • VidPrevtyn® Beta vaccine (Sanofi/GSK)
    • Paris, France
      CIC 1417 Cochin-Pasteur
    Feb 28, 2023

    Hepatitis B, Chronic Trial in Hefei (PEGylated recombinant human interferon alpha-2b injection)

    Recruiting
    • Hepatitis B, Chronic
    • PEGylated recombinant human interferon alpha-2b injection
    • Hefei, Anhui, China
      The First Affiliated Hospital of Anhui Medical University
    Jun 24, 2023

    Chronic Hepatitis B Trial (PEG IFN a-2b; TAF)

    Not yet recruiting
    • Chronic Hepatitis B
    • PEG IFN α-2b; TAF
    • (no location specified)
    Aug 5, 2022

    Lactose Intolerance Trial in West Lafayette (Milk containing A1 and A2 beta-casein, Milk containing only A2 beta-casein)

    Recruiting
    • Lactose Intolerance
    • Milk containing A1 and A2 beta-casein
    • Milk containing only A2 beta-casein
    • West Lafayette, Indiana
      Purdue University
    Dec 20, 2022

    Lactose Intolerance, Adult Type Trial in West Lafayette (Milk containing A1 and A2 beta-casein, Milk containing only A2

    Active, not recruiting
    • Lactose Intolerance, Adult Type
    • Milk containing A1 and A2 beta-casein
    • Milk containing only A2 beta-casein
    • West Lafayette, Indiana
      Purdue MRI Facility
    Dec 17, 2022

    Exercise-Induced Lactic Acidemia Trial in Saskatoon (Beta-alanine, Maltodextrin)

    Recruiting
    • Exercise-Induced Lactic Acidemia
    • Beta-alanine
    • Maltodextrin
    • Saskatoon, Saskatchewan, Canada
      University of Saskatchewan
    Mar 14, 2023

    Advanced Malignant Solid Tumor, Hepatocellular Carcinoma Trial in Scottsdale (Laboratory Biomarker Analysis, Pharmacological

    Active, not recruiting
    • Advanced Malignant Solid Neoplasm
    • Hepatocellular Carcinoma
    • Laboratory Biomarker Analysis
    • +2 more
    • Scottsdale, Arizona
      Mayo Clinic in Arizona
    Oct 6, 2021

    Healthy Trial in Maastricht (Clenbuterol Hydrochloride, Placebos)

    Completed
    • Healthy
    • Clenbuterol Hydrochloride
    • Placebos
    • Maastricht, Limburg, Netherlands
      Maastricht University
    Nov 28, 2022

    Healthy Trial in Edmonton (Salbutamol 400mcg, Budesonide/formoterol, Placebo)

    Recruiting
    • Healthy
    • Salbutamol 400mcg
    • +2 more
    • Edmonton, Alberta, Canada
      Clinical Physiology Laboratory
    Sep 5, 2023

    type1diabetes, Type2diabetes, Pre Diabetes Trial in Parma (68Ga-exendin-4, mixed meal test)

    Recruiting
    • type1diabetes
    • +3 more
    • Parma, Pr, Italy
      Azienda Ospedaliero Universitaria di Parma
    Dec 20, 2022

    Type 2 Diabetes in Obese, Obesity, Type2Diabetes Trial in San Diego (SPI-62, Cortisone-d8)

    Completed
    • Type 2 Diabetes Mellitus in Obese
    • +2 more
    • Chula Vista, California
      ProSciento
    Jan 26, 2023

    COVID-19 Pandemic Trial in China (SCTV01E, Placebo (normal saline))

    Recruiting
    • COVID-19 Pandemic
    • SCTV01E
    • Placebo (normal saline)
    • Lianshui, Jiangsu, China
    • +3 more
    Jan 5, 2023

    Lactose Intolerance Trial in West Lafayette (Milk containing A1 and A2 beta-casein, Milk containing only A2 beta-casein)

    Recruiting
    • Lactose Intolerance
    • Milk containing A1 and A2 beta-casein
    • Milk containing only A2 beta-casein
    • West Lafayette, Indiana
      Purdue University
    Dec 20, 2022

    Thermogenesis Trial in Basel (Fenoterol, Mild cold exposure)

    Recruiting
    • Thermogenesis
    • Basel, Switzerland
      University Hospital Basel, Dept. of Endocrinology
    Apr 27, 2022

    Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in

    Recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +2 more
    • Best Practice
    • +2 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Mar 1, 2022

    Leiomyosarcoma Trial in Bad Saarow, Berlin (Dinutuximab Beta, Zoledronic acid, Interleukin-2)

    Recruiting
    • Leiomyosarcoma
    • Dinutuximab Beta, Zoledronic acid, Interleukin-2
    • Bad Saarow, Germany
    • +1 more
    Jun 2, 2022

    Stable Ischemic Heart Disease, Coronary Artery Disease, Beta-blocker Therapy Trial in Edmonton (Medical Assessment, Quality of

    Recruiting
    • Stable Ischemic Heart Disease
    • +2 more
    • Medical Assessment
    • Quality of Life Assessment
    • Edmonton, Alberta, Canada
      University of Alberta Hospital
    Jan 30, 2023

    Covid19 Trial in Australia (SII B.1.351, SII Bivalent, SII B.1.617.2)

    Withdrawn
    • Covid19
    • SII B.1.351
    • +2 more
    • Maroubra, New South Wales, Australia
    • +3 more
    May 25, 2022

    Visualizing Beta Cells After Bariatric Surgery

    Recruiting
    • Type 2 Diabetes Mellitus
    • 68Ga-exendin PET/CT
    • Arnhem, Gelderland, Netherlands
    • +1 more
    Jun 16, 2022